サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1588395

アダプトゲンの市場規模、シェア、動向分析レポート：性質別、タイプ別、形態別、流通チャネル別、地域別、セグメント予測、2024年～2030年

Adaptogens Market Size, Share & Trends Analysis Report By Nature (Organic, Synthetic), By Type (Ashwagandha, Ginseng, Tulsi), By Form (Capsules, Powder, Teas & Beverages), By Distribution Channel (B2B, B2C), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.72円
アダプトゲンの市場規模、シェア、動向分析レポート：性質別、タイプ別、形態別、流通チャネル別、地域別、セグメント予測、2024年～2030年
出版日: 2024年10月03日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アダプトゲン市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のアダプトゲン市場規模は2030年までに163億2,000万米ドルに達し、2024～2030年のCAGRは7.0％で成長すると予測されています。

健康志向が高まるにつれ、人々はストレス、不安、疲労の管理に役立つホリスティックなソリューションを求めるようになっています。アダプトゲンは植物やキノコ由来の天然物質で、身体がストレスに適応するのを助ける。このような自然健康法へのシフトは、消費者がウェルネスと予防医療を優先するという、より広範な傾向と一致しています。

アダプトジェニック成分の抽出と製剤化における技術の進歩も、市場の拡大に重要な役割を果たしています。改良された方法によって、これらの化合物のより高い効力とより優れた生物学的利用能が可能になり、消費者にとってより魅力的なものとなっています。アシュワガンダ、ロディオラ、高麗人参など、アダプトジェニックハーブの多様な効能が研究によって明らかにされ続けるにつれて、消費者の認識と受容は高まり、市場の需要をさらに促進すると予想されます。

アダプトゲンが様々な製品カテゴリーに統合されていることも、市場の成長を後押しする重要な動向です。アダプトゲンを機能性食品、飲食品、栄養補助食品、さらには化粧品に配合するケースが増えています。この多用途性により、消費者はスムージー、茶、スキンケア製品など、日常生活にこれらの有益な成分を簡単に取り入れることができます。機能性食品--基本的な栄養を超えた健康上のメリットを提供する製品--への動向は、アダプトゲン入りアイテムの需要を特に押し上げています。

さらに、eコマースの台頭は、アダプトゲン製品を消費者にとってより身近なものにしました。オンラインショッピングプラットフォームは、個人がさまざまなブランドの幅広いアダプトゲン製品を探索する便利な方法を提供し、製品レビューや詳細な情報を通じて十分な情報に基づいた購入決定を容易にしています。COVID-19の流行は、消費者が自分の健康ニーズに便利な選択肢を求めているため、オンライン小売へのシフトをさらに加速させています。

アダプトゲン市場のハイライト

  • 性質別では、合成アダプトゲンが2023年に76.4%のシェアを占める。予測可能な効果、安全性プロファイル、幅広い製品への統合のしやすさから、医薬品産業と機能性食品産業は合成アダプトゲンをますます取り入れるようになっています。この動向は、精神的肉体的な幸福感を高めることを目的としたサプリメント、栄養補助食品、機能性飲料における合成アダプトゲンの使用の増加に寄与しています。
  • 健康とウェルネスに対する意識の高まりとともに、消費者は心身の健康をサポートする天然のソリューションを求めるようになっています。トゥルシーは抗炎症、抗酸化、ストレス緩和の特性が認められており、全体的な健康増進を求める人々に人気のある選択肢となっています。
  • 飲料市場は大きな革新を遂げ、さまざまなフレーバーや組み合わせが利用できるようになっています。多くのブランドは、アダプトゲンを様々なハーブ、スパイス、天然フレーバーと創造的にブレンドし、これらの飲料をより多くの人々にとって楽しく魅力的なものにしています。この多様性は、消費者がアダプトゲン飲料を毎日のルーティンの一部として試してみることを促しています。
  • 流通チャネル別に見ると、2023年の市場シェアはB2Bが79.7%を占めています。ビーガン、グルテンフリー、ケトフレンドリー製品といったニッチ市場の台頭が、アダプトゲン需要を牽引しています。B2Bサプライヤーは、特定の食事要件や健康強調表示を満たすアダプトゲン成分を提供することで、こうした特殊な市場に対応することができ、健康とウェルネス産業における多様な製品ラインの成長を促進します。
  • 地域別に見ると、アジア太平洋は2024～2030年にかけてCAGR 7.8％で成長すると予想されています。アジア太平洋では、高麗人参やアシュワガンダのようなアダプトゲンは、アーユルヴェーダや中国伝統医療（TCM）のような伝統医療の体系で長い間使用されてきました。長い歴史を持つ自然療法への回帰への関心の高まりが、現代的なウェルネス製品と伝統的健康法の両方におけるアダプトゲン需要を押し上げています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 アダプトゲン市場の変数、動向、範囲

  • 市場系統の展望
  • 産業バリューチェーン分析
    • 販売/小売チャネル分析
    • 利益率分析
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 産業の課題
    • 産業の機会
  • 産業分析-ポーターのファイブフォース分析
  • 市場参入戦略

第4章 アダプトゲン市場：性質別、分析と推定

  • アダプトゲン市場、性質別：主要ポイント
  • 性質変動分析と市場シェア、2023年と2030年
  • 性質別、2018～2030年

第5章 アダプトゲン市場：タイプ別、分析と推定

  • アダプトゲン市場、タイプ別：主要ポイント
  • タイプ変動分析と市場シェア、2023年と2030年
  • タイプ別、2018～2030年

第6章 アダプトゲン市場：形態別、推定動向分析

  • アダプトゲン市場、形態別：主要ポイント
  • 形態変動分析と市場シェア、2023年と2030年
  • 形態別、2018～2030年
    • カプセル
    • 粉末
    • 茶と飲み物
    • その他

第7章 アダプトゲン市場：流通チャネル別、推定動向分析

  • アダプトゲン市場、流通チャネル別：主要ポイント
  • 流通チャネル変動分析と市場シェア、2023年と2030年
  • 流通チャネル別、2018～2030年
    • 企業向け
    • B2C

第8章 アダプトゲン市場：地域別、推定動向分析

  • アダプトゲン市場：地域別展望
  • 地域変動分析と市場シェア、2023年と2030年
  • 地域別国別、2018～2030年
    • 北米
    • 欧州
    • アジア太平洋
    • 中南米
    • 中東アフリカ

第9章 競合分析

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 参入企業概要
  • 企業市場シェア分析、2023年（％）
  • 企業ヒートマップ分析
  • 戦略マッピング
  • 企業プロファイル
  • Nutraceutical International Corporation
  • Organic India Private Limited
  • Himalaya Global Holdings Ltd.
  • Rejuvenating Herbs &Nutrition, Inc.（REBBL）
  • Embria Health Sciences, LLC
  • Natreon, Inc.
  • Amax NutraSource, Inc.
  • PLT Health Solutions, Inc.
  • Xiamen Kingdomway Group Company
  • KSM-66 Ashwagandha（Ixoreal Biomed Inc.）
図表

List of Tables

  • 1. Adaptogens market - Key market driver analysis
  • 2. Adaptogens market - Key market restraint analysis
  • 3. Organic adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 4. Synthetic adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 5. Ashwagandha market estimates and forecast, 2018 - 2030 (USD Million)
  • 6. Ginseng market estimates and forecast, 2018 - 2030 (USD Million)
  • 7. Tulsi market estimates and forecast, 2018 - 2030 (USD Million)
  • 8. Cordyceps market estimates and forecast, 2018 - 2030 (USD Million)
  • 9. Other adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 10. Adaptogens market estimates and forecast, in capsules, 2018 - 2030 (USD Million)
  • 11. Adaptogens market estimates and forecast, in powder, 2018 - 2030 (USD Million)
  • 12. Adaptogens market estimates and forecast, in teas & beverages, 2018 - 2030 (USD Million)
  • 13. Adaptogens market estimates and forecast, in other form, 2018 - 2030 (USD Million)
  • 14. Adaptogens market estimates and forecast, through B2B, 2018 - 2030 (USD Million)
  • 15. Adaptogens market estimates and forecast, through B2C, 2018 - 2030 (USD Million)
  • 16. Adaptogens market estimates and forecast, through supermarkets & hypermarkets, 2018 - 2030 (USD Million)
  • 17. Adaptogens market estimates and forecast, through convenience stores, 2018 - 2030 (USD Million)
  • 18. Adaptogens market estimates and forecast, through online, 2018 - 2030 (USD Million)
  • 19. Adaptogens market estimates and forecast, through others, 2018 - 2030 (USD Million)
  • 20. North America adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 21. North America adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 22. North America adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 23. North America adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 24. North America adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 25. U.S. macro-economic outlay
  • 26. U.S. adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 27. U.S. adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 28. U.S. adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 29. U.S. adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 30. U.S. adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 31. Canada macro-economic outlay
  • 32. Canada adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 33. Canada adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 34. Canada adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 35. Canada adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 36. Canada adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 37. Mexico macro-economic outlay
  • 38. Mexico adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 39. Mexico adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 40. Mexico adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 41. Mexico adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 42. Mexico adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 43. Europe adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 44. Europe adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 45. Europe adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 46. Europe adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 47. Europe adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 48. Germany macro-economic outlay
  • 49. Germany adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 50. Germany adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 51. Germany adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 52. Germany adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 53. UK macro-economic outlay
  • 54. UK adaptogens market estimates and forecast, 2018 - 2030 (USD Million, Metric Tons)
  • 55. UK adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 56. UK adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 57. UK adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 58. UK adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 59. Spain macro-economic outlay
  • 60. Spain adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 61. Spain adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 62. Spain adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 63. Spain adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 64. Spain adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 65. Italy macro-economic outlay
  • 66. Italy adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 67. Italy adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 68. Italy adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 69. Italy adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 70. Italy adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 71. France macro-economic outlay
  • 72. France adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 73. France adaptogens market revenue estimates and forecast, by Nature, 2018 - 2030 (USD Million)
  • 74. France adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 75. France adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 76. France adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 77. Asia Pacific adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 78. Asia Pacific adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 79. Asia Pacific adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 80. Asia Pacific adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 81. Asia Pacific adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 82. China macro-economic outlay
  • 83. China adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 84. China adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 85. China adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 86. China adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 87. China adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 88. India macro-economic outlay
  • 89. India adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 90. India adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 91. India adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 92. India adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 93. India adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 94. Japan macro-economic outlay
  • 95. Japan adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 96. Japan adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 97. Japan adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 98. Japan adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 99. Japan adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 100. South Korea macro-economic outlay
  • 101. South Korea adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 102. South Korea adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 103. South Korea adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 104. South Korea adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 105. South Korea adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 106. Australia & New Zealand macro-economic outlay
  • 107. Australia & New Zealand adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 108. Australia & New Zealand adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 109. Australia & New Zealand adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 110. Australia & New Zealand adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 111. Australia & New Zealand adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 112. Central & South America adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 113. Central & South America adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 114. Central & South America adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 115. Central & South America adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 116. Central & South America adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 117. Brazil macro-economic outlay
  • 118. Brazil adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 119. Brazil adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 120. Brazil adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 121. Brazil adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 122. Brazil adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 123. Middle East & Africa adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 124. Middle East & Africa adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 125. Middle East & Africa adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 126. Middle East & Africa adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 127. Middle East & Africa adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • 128. UAE adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 129. UAE adaptogens market revenue estimates and forecast, by nature, 2018 - 2030 (USD Million)
  • 130. UAE adaptogens market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • 131. UAE adaptogens market revenue estimates and forecast, by form, 2018 - 2030 (USD Million)
  • 132. UAE adaptogens market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • 1. Adaptogens market snapshot
  • 2. Adaptogens market segmentation & scope
  • 3. Adaptogens market penetration & growth prospect mapping
  • 4. Adaptogens market value chain analysis
  • 5. Adaptogens market dynamics
  • 6. Adaptogens market Porter's Five Forces analysis
  • 7. Adaptogens market: Nature movement analysis, 2023 & 2030 (%)
  • 8. Organic adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 9. Synthetic adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 10. Adaptogens market: Type movement analysis, 2023 & 2030 (%)
  • 11. Ashwagandha market estimates and forecast, 2018 - 2030 (USD Million)
  • 12. Ginseng market estimates and forecast, 2018 - 2030 (USD Million)
  • 13. Tulsi market estimates and forecast, 2018 - 2030 (USD Million)
  • 14. Cordyceps market estimates and forecast, 2018 - 2030 (USD Million)
  • 15. Other adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 16. Adaptogens market: Form movement analysis, 2023 & 2030 (%)
  • 17. Adaptogens market estimates and forecast, in capsules, 2018 - 2030 (USD Million)
  • 18. Adaptogens market estimates and forecast, in powder, 2018 - 2030 (USD Million)
  • 19. Adaptogens market estimates and forecast, in teas & beverages, 2018 - 2030 (USD Million)
  • 20. Adaptogens market estimates and forecast, in other form, 2018 - 2030 (USD Million)
  • 21. Adaptogens market: Distribution channel movement analysis, 2023 & 2030 (%)
  • 22. Adaptogens market estimates and forecast, through B2B, 2018 - 2030 (USD Million)
  • 23. Adaptogens market estimates and forecast, through B2C, 2018 - 2030 (USD Million)
  • 24. Adaptogens market estimates and forecast, through supermarkets & hypermarkets, 2018 - 2030 (USD Million)
  • 25. Adaptogens market estimates and forecast, through convenience stores, 2018 - 2030 (USD Million)
  • 26. Adaptogens market estimates and forecast, through online, 2018 - 2030 (USD Million)
  • 27. Adaptogens market estimates and forecast, through others, 2018 - 2030 (USD Million)
  • 28. Adaptogens market: Regional movement analysis, 2023 & 2030 (%)
  • 29. North America adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 30. U.S. adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 31. Canada adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 32. Mexico adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 33. Europe adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 34. Germany adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 35. UK adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 36. Spain adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 37. Italy adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 38. France adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 39. Asia Pacific adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 40. China adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 41. India adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 42. Japan adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 43. South Korea adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 44. Australia & New Zealand adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 45. Central & South America adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 46. Brazil adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 47. Middle East & Africa adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
  • 48. UAE adaptogens market estimates and forecast, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-477-9

Adaptogens Market Growth & Trends:

The global adaptogens market size is expected to reach USD 16.32 billion by 2030, growing at a CAGR of 7.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. As people become more health-conscious, they are seeking holistic solutions that can help manage stress, anxiety, and fatigue. Adaptogens, which are natural substances derived from plants and mushrooms that help the body adapt to stress, have gained popularity for their potential benefits in enhancing mental clarity and overall vitality. This shift towards natural health solutions aligns with a broader trend of consumers prioritizing wellness and preventive care.

Technological advancements in the extraction and formulation of adaptogenic ingredients have also played a crucial role in market expansion. Improved methods allow for higher potency and better bioavailability of these compounds, making them more appealing to consumers. As research continues to unveil the diverse benefits of adaptogenic herbs, such as ashwagandha, Rhodiola, and ginseng, consumer awareness and acceptance are expected to grow, further driving market demand.

The integration of adaptogens into various product categories is another significant trend fueling market growth. Adaptogens are increasingly being incorporated into functional foods, beverages, dietary supplements, and even cosmetics. This versatility allows consumers to easily incorporate these beneficial ingredients into their daily routines, whether through smoothies, teas, or skincare products. The trend towards functional foods-products that offer health benefits beyond basic nutrition-has particularly boosted the demand for adaptogen-infused items.

Additionally, the rise of e-commerce has made adaptogen products more accessible to consumers. Online shopping platforms provide a convenient way for individuals to explore a wide range of adaptogenic products from various brands, facilitating informed purchasing decisions through product reviews and detailed information. The COVID-19 pandemic has further accelerated this shift towards online retail, as consumers seek convenient options for their health needs.

Adaptogens Market Report Highlights:

  • Based on nature, synthetic adaptogens accounted for a share of 76.4% in 2023.The pharmaceutical and functional food industries are increasingly incorporating synthetic adaptogens due to their predictable effects, safety profile, and the ease of integration into a wide range of products. This trend is contributing to the growing use of synthetic adaptogens in supplements, nutraceuticals, and functional beverages aimed at boosting mental and physical well-being.
  • Based on type, Tulsi is expected to grow at a CAGR of 7.1% from 2024 to 2030.With growing awareness of health and wellness, consumers are increasingly looking for natural solutions to support their physical and mental well-being. Tulsi is recognized for its anti-inflammatory, antioxidant, and stress-relief properties, making it a popular choice for those seeking to enhance their overall health.
  • Based on form, teas & beverages is expected to grow at a CAGR of 7.1% from 2024 to 2030.The beverage market is seeing significant innovation, with a wide range of flavors and combinations available. Many brands are creatively blending adaptogens with various herbs, spices, and natural flavors, making these drinks enjoyable and attractive to a broader audience. This variety encourages consumers to try adaptogenic beverages as part of their daily routine.
  • Based on distribution channel, B2B accounted for a market share of 79.7% in 2023. The rise of niche markets, such as vegan, gluten-free, and keto-friendly products, is driving demand for adaptogens. B2B suppliers can cater to these specialized markets by providing adaptogenic ingredients that meet specific dietary requirements and health claims, facilitating the growth of diverse product lines within the health and wellness industry.
  • Based on region, Asia Pacific is expected to grow at a CAGR of 7.8% from 2024 to 2030. In Asia Pacific, adaptogens such as ginseng and ashwagandha have long been used in traditional medicine systems like Ayurveda and Traditional Chinese Medicine (TCM). The growing interest in returning to natural, time-tested remedies is boosting the demand for adaptogens in both modern wellness products and traditional health practices.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Natures & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Information & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Nature Outlook
  • 2.3. Type Outlook
  • 2.4. Form Outlook
  • 2.5. Distribution Channel Outlook
  • 2.6. Regional Outlook
  • 2.7. Competitive Insights

Chapter 3. Adaptogens Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Sales/Retail Channel Analysis
    • 3.2.2. Profit Margin Analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
    • 3.3.3. Industry Challenges
    • 3.3.4. Industry Opportunities
  • 3.4. Industry Analysis - Porter's Five Force Analysis
  • 3.5. Market Entry Strategies

Chapter 4. Adaptogens Market: Nature Analysis & Estimates

  • 4.1. Adaptogens Market, by Nature: Key Takeaways
  • 4.2. Nature Movement Analysis & Market Share, 2023 & 2030
  • 4.3. Market Estimates & Forecasts, by Nature, 2018 - 2030 (USD Million)
    • 4.3.1. Organic
      • 4.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.3.2. Synthetic
      • 4.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Adaptogens Market: Type Analysis & Estimates

  • 5.1. Adaptogens Market, by Type: Key Takeaways
  • 5.2. Type Movement Analysis & Market Share, 2023 & 2030
  • 5.3. Market Estimates & Forecasts, by Type, 2018 - 2030 (USD Million)
    • 5.3.1. Ashwagandha
      • 5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.2. Ginseng
      • 5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.3. Tulsi
      • 5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.4. Cordyceps
      • 5.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.5. Others
      • 5.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Adaptogens Market: Form Estimates & Trend Analysis

  • 6.1. Adaptogens Market, by Form: Key Takeaways
  • 6.2. Form Movement Analysis & Market Share, 2023 & 2030
  • 6.3. Market Estimates & Forecasts, by Form, 2018 - 2030 (USD Million)
    • 6.3.1. Capsules
      • 6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.2. Powder
      • 6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. Teas & Beverages
      • 6.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. Others
      • 6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Adaptogens Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Adaptogens Market, by Distribution Channel: Key Takeaways
  • 7.2. Distribution Channel Movement Analysis & Market Share, 2023 & 2030
  • 7.3. Market Estimates & Forecasts, by Distribution Channel, 2018 - 2030 (USD Million)
    • 7.3.1. B2B
      • 7.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.2. B2C
      • 7.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.2.2. Supermarkets & Hypermarkets
        • 7.3.2.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.2.3. Convenience Stores
        • 7.3.2.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.2.4. Online
        • 7.3.2.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.2.5. Others
        • 7.3.2.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Adaptogens Market: Regional Estimates & Trend Analysis

  • 8.1. Adaptogens Market: Regional Outlook
  • 8.2. Regional Movement Analysis & Market Share, 2023 & 2030
  • 8.3. Market Estimates & Forecasts, by Region & Country, 2018 - 2030 (USD Million)
    • 8.3.1. North America
      • 8.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.1.2. U.S.
        • 8.3.1.2.1. Key country dynamics
        • 8.3.1.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.1.3. Canada
        • 8.3.1.3.1. Key country dynamics
        • 8.3.1.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.1.4. Mexico
        • 8.3.1.4.1. Key country dynamics
        • 8.3.1.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.2. Europe
      • 8.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.2.2. UK
        • 8.3.2.2.1. Key country dynamics
        • 8.3.2.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.2.3. Germany
        • 8.3.2.3.1. Key country dynamics
        • 8.3.2.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.2.4. France
        • 8.3.2.4.1. Key country dynamics
        • 8.3.2.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.2.5. Spain
        • 8.3.2.5.1. Key country dynamics
        • 8.3.2.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.2.6. Italy
        • 8.3.2.6.1. Key country dynamics
        • 8.3.2.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.3. Asia Pacific
      • 8.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.3.2. China
        • 8.3.3.2.1. Key country dynamics
        • 8.3.3.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.3.3. Japan
        • 8.3.3.3.1. Key country dynamics
        • 8.3.3.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.3.4. India
        • 8.3.3.4.1. Key country dynamics
        • 8.3.3.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.3.5. South Korea
        • 8.3.3.5.1. Key country dynamics
        • 8.3.3.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.3.6. Australia & New Zealand
        • 8.3.3.6.1. Key country dynamics
        • 8.3.3.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.4. Central & South America
      • 8.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.4.2. Brazil
        • 8.3.4.2.1. Key country dynamics
        • 8.3.4.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.3.5. Middle East & Africa
      • 8.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.3.5.2. UAE
        • 8.3.5.2.1. Key country dynamics
        • 8.3.5.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Analysis

  • 9.1. Recent developments & impact analysis, by key market participants
  • 9.2. Company Categorization
  • 9.3. Participant's Overview
  • 9.4. Financial Performance
  • 9.5. Product Benchmarking
  • 9.6. Company Market Share Analysis, 2023 (%)
  • 9.7. Company Heat Map Analysis
  • 9.8. Strategy Mapping
  • 9.9. Company Profiles
  • 9.10. Nutraceutical International Corporation
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Strategic Initiatives
  • 9.11. Organic India Private Limited
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Strategic Initiatives
  • 9.12. Himalaya Global Holdings Ltd.
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Strategic Initiatives
  • 9.13. Rejuvenating Herbs & Nutrition, Inc. (REBBL)
    • 9.13.1. Company Overview
    • 9.13.2. Financial Pertypeance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Strategic Initiatives
  • 9.14. Embria Health Sciences, LLC
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Strategic Initiatives
  • 9.15. Natreon, Inc.
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Strategic Initiatives
  • 9.16. Amax NutraSource, Inc.
    • 9.16.1. Company Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Strategic Initiatives
  • 9.17. PLT Health Solutions, Inc.
    • 9.17.1. Company Overview
    • 9.17.2. Financial Performance
    • 9.17.3. Product Benchmarking
    • 9.17.4. Strategic Initiatives
  • 9.18. Xiamen Kingdomway Group Company
    • 9.18.1. Company Overview
    • 9.18.2. Financial Performance
    • 9.18.3. Product Benchmarking
    • 9.18.4. Strategic Initiatives
  • 9.19. KSM-66 Ashwagandha (Ixoreal Biomed Inc.)
    • 9.19.1. Company Overview
    • 9.19.2. Financial Performance
    • 9.19.3. Product Benchmarking
    • 9.19.4. Strategic Initiatives